Semi-Quantitative Ultrasonographic Evaluation of NAFLD

Area of Science:

• Hepatology
• Cardiology
• Radiology

Background:

• Nonalcoholic fatty liver disease (NAFLD) spectrum ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), linked to fibrosis, cirrhosis, and cancer.
• NAFLD is prevalent globally and significantly contributes to cardiovascular disease burden.
• Accurate non-invasive diagnosis and risk stratification are crucial for personalized NAFLD management.

Purpose of the Study:

• To review the utility of semiquantitative ultrasound scores in NAFLD assessment.
• To explore the role of these scores in evaluating steatosis severity and disease progression.
• To highlight their potential in identifying cardio-metabolic risk in NAFLD patients.

Main Methods:

• Review of existing literature on ultrasound semiquantitative scoring for NAFLD.
• Analysis of studies correlating ultrasound findings with histopathological severity and clinical outcomes.
• Evaluation of ultrasound scores as predictors of cardio-metabolic risk.

Main Results:

• Semiquantitative ultrasound scores effectively detect and grade hepatic steatosis.
• These scores show potential in monitoring NAFLD progression.
• Ultrasound scores correlate with cardio-metabolic risk factors and outcomes.

Conclusions:

• Ultrasound semiquantitative scores are valuable non-invasive tools for NAFLD assessment.
• They can serve as indicators of overall cardio-metabolic health in NAFLD patients.
• These scores can guide the selection of patients for advanced diagnostic procedures.